Related references
Note: Only part of the references are listed.Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response
Fatima Karzai et al.
CLINICAL CANCER RESEARCH (2021)
Genomic and phenotypic heterogeneity in prostate cancer
Michael C. Haffner et al.
NATURE REVIEWS UROLOGY (2021)
Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials
Rana R. McKay et al.
JOURNAL OF UROLOGY (2021)
The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature
Raisa S. Abrams-Pompe et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
The evolutionary history of 2,658 cancers
Moritz Gerstung et al.
NATURE (2020)
A case report of multiple primary prostate tumors with differential drug sensitivity
Scott Wilkinson et al.
NATURE COMMUNICATIONS (2020)
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone
Rana R. McKay et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Abiraterone acetate plus prednisone in patients with newly Croatia& diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
Karim Fizazi et al.
LANCET ONCOLOGY (2019)
Abiraterone in High- and Low-risk Metastatic Hormone-sensitive Prostate Cancer
Alex P. Hoyle et al.
EUROPEAN UROLOGY (2019)
Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations
Adam G. Sowalsky et al.
CANCER RESEARCH (2018)
The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression
Shadrielle Melijah G. Espiritu et al.
CELL (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia et al.
NATURE GENETICS (2018)
Neoadjuvant Enzalutamide Prior to Prostatectomy
Bruce Montgomery et al.
CLINICAL CANCER RESEARCH (2017)
Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4
Adam G. Sowalsky et al.
CLINICAL CANCER RESEARCH (2017)
Clonality of localized and metastatic prostate cancer
Paul C. Boutros et al.
CURRENT OPINION IN UROLOGY (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
F. C. Hamdy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mutation Profiling Indicates High Grade Prostatic Intraepithelial Neoplasia as Distant Precursors of Adjacent Invasive Prostatic Adenocarcinoma
Sean J. Gerrin et al.
PROSTATE (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem et al.
NATURE (2015)
Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors
Eddy J. Chen et al.
CLINICAL CANCER RESEARCH (2015)
Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial
Gerhardt Attard et al.
EUROPEAN UROLOGY (2014)
Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study
Mary-Ellen Taplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4
Adam G. Sowalsky et al.
CANCER RESEARCH (2013)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Share Paper
